Table 1.
Phenotypical marker | pDC | Lymphoid tissue cDC | Nonlymphoid tissue cDC | Langerhans cell | |||
---|---|---|---|---|---|---|---|
CD8+ cDC | CD11b+ cDC | CD103+ CD11b− cDC | CD103+ CD11b+ intestinal cDC | CD103− CD11b+ cDC | |||
CD45 | + | + | + | + | + | + | + |
CD11c | + | +++ | +++ | ++ | ++ | ++ | ++ |
MHC class II | + | ++ | ++ | ++ | ++ | ++ | ++ |
CD8 | subset | + | − | − | − | − | − |
CD4 | + | − | +/− | − | − | − | ND |
CD11b | − | − | + | − | + | + | + |
CD103 | − | subset | − | ++ | ++ | − | − |
Langerin | − | subset | − | + | − | − | ++ |
EpCAM | − | − | − | − | − | − | ++ |
B220 | + | − | − | − | − | − | − |
CD24 | ND | ++ | + | ++ | ++ | +/− | ++ |
Btla | + | ++ | + | ++ | + | +/− | ND |
c-kit | − | + | + | + | + | +/− | ND |
CD26 | + | + | + | + | + | +/− | ND |
Xcr1 | − | + | − | + | − | − | − |
CD36 | − | + | − | + | ND | − | − |
Cystatin C | + | ++ | + | ND | ND | ND | ND |
Clec9a (DNGR1) | + | ++ | − | ++ | − | − | − |
Cadm1 (Necl2) | − | + | − | ND | ND | ND | ND |
CD205 | − | ++ | + | ++ | ND | ND | ++ |
CX3CR1 | − | subset | − | − | − | ++ | + |
CD209 (dc-sign) | ++ | − | + | − | + | +/− | − |
F4/80 | − | − | + | − | − | + | + |
CD172a (Sirpa) | + | − | ++ | − | − | ++ | + |
CD64 (Fc r1) | − | − | − | − | − | ++ | ND |
Ly6C | ++ | − | − | − | − | +/− | − |
ND, not determined.